Day: March 16, 2023

Award recognizes NeuroStar for its significant contributions toward patient wellbeing MALVERN, Pa., March 16, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is named a recipient of Life Sciences Pennsylvania’s (LSPA) annual Patient Impact Award for 2022. “We are honored that Life Sciences Pennsylvania has identified NeuroStar as a recipient of the Patient Impact Award,” said Keith J. Sullivan, President and CEO of Neuronetics. “We take pride in positively impacting the lives of individuals suffering from depression and other mental health conditions. We believe they deserve a safe, effective, and non-invasive treatment option when traditional...

Highlights:Incannex plans to open multiple psychedelic-assisted psychotherapy clinics in Australia and overseas. First clinic will open in Melbourne in 2023, followed by rapid expansion based on development of sound operating model. Dr. Paul Liknaitzky, Professor Suresh Sundram and Sean O’Carroll to join the Board of Directors of a subsidiary company and take key roles within the venture. Incannex owned subsidiary is being led by long time Incannex director, Mr Peter Widdows. Advanced stage of negotiation on riverfront premises in Melbourne for first clinic. Incannex believes the market will mature into a multi-billion-dollar opportunity.MELBOURNE, Australia, March 16, 2023 (GLOBE NEWSWIRE) — Incannex Healthcare Ltd (Nasdaq: IXHL). (ASX: IHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal...

The WIN Consortium partners include leading companies and academic institutions such as Elbit Systems (Nasdaq: ESLT), CEVA (Nasdaq: CEVA), Ceragon Networks (Nasdaq: CRNT) and Ben Gurion University Mobilicom worked closely with the consortium partners to develop and test AI and machine learning (ML) in a 5G field test of device-to-device systems for applications including drones and drone security Other applications include autonomous vehicles and drones for industrial and defense needsShoham, Israel, March 16, 2023 (GLOBE NEWSWIRE) — Mobilicom Limited (Mobilicom or the Company) (Nasdaq: MOB, MOBBW, ASX: MOB) a provider of cybersecurity and robust solutions for drones and robotics, in conjunction with the Wireless Intelligent Networks (WIN) Consortium, today announced the successful demonstration of artificial intelligence (AI)...

Growing body of data supports Ampligen’s potential as both a prophylactic and an early-onset therapy against human Ebola virus disease outbreaks OCALA, Fla., March 16, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases — including COVID-19, the disease caused by the SARS-CoV-2 virus — today announced a late-breaking presentation at the 36th International Conference on Antiviral Research (ICAR) detailing Ampligen’s mechanism of action in the treatment of Ebola virus disease (EVD). The presentation was given by Angela Corona, PhD, Department of Life and Environmental Sciences, University of Cagliari, Monserrato, Italy, and one of the published...

New research released at ACMG Annual Clinical Genetics Meeting reiterates the superiority of exome sequencing’s role in shortening the diagnostic odyssey STAMFORD, Conn., March 16, 2023 (GLOBE NEWSWIRE) — GeneDx Holdings Corp. (GeneDx) (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, announced new research today at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting which demonstrates exome sequencing’s diagnostic advantages in shortening patients’ and families’ diagnostic odysseys when compared with chromosomal microarray (CMA). To determine whether exome sequencing is comparable to CMA with respect to copy number variant (CNV) yield, GeneDx compared the reported CNV results on over 8,000 probands who had CMA and exome sequencing between...

LONDON, March 16, 2023 – Stolt-Nielsen Limited (Oslo Børs: SNI) has today published its Annual Report for the financial year ended November 30, 2022. The report is available to view on the company’s website. You can also find downloadable files, including XBRL and EFES formats of the full report here: stolt-nielsen.com/annual-report-2022/ Highlights include:A review of Stolt-Nielsen Limited’s financial performance for the year Business reviews from each division Stolt-Nielsen’s approach to sustainability, including health and safety, environmental and people performance ‘2022 in Review’ filmFor additional information please contact:  Investor Relations Jens F. Grüner-Hegge Chief Financial Officer +44 (0) 20 7611 8985j.gruner-hegge@stolt.com Media Enquiries Ellie Davison Head of Corporate Communications +44 (0) 20 7611...

On 16 March 2023 the Annual General Meeting (the “Meeting”) in Pandora A/S (the “Company”) was held. The Meeting considered the following agenda items.The Board of Directors’ (the “Board”) report on the Company’s activities during the past financial yearThe report was not subject to voting. The Meeting took note of the report.Adoption of the audited 2022 Annual Report The audited 2022 Annual Report was adopted.Presentation of the 2022 Remuneration ReportAn advisory vote was cast for approval of the 2022 Remuneration Report.                          Adoption of proposal on the Board’s remuneration for 2023The proposed remuneration to the Board for 2023 was adopted.The fixed base fee amounts to DKK 550,000. The chair of the Board receives 3 times the fixed base fee, whereas the deputy chair receives 1.5 times...